Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Dalton Trans ; 52(28): 9590-9606, 2023 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-37377063

RESUMO

We describe the synthesis, physicochemical characterization, and in vitro antitumor assays of four novel analogous ruthenium(II) complexes with general formula cis-[RuII(N-L)(P-P)2]PF6, where P-P = bis(diphenylphosphine)methane (dppm, in complexes 1 and 2) or bis(diphenylphosphine)ethane (dppe, in complexes 3 and 4) and N-L = 5,6-diphenyl-4,5-dihydro-2H-[1,2,4]triazine-3-thione (Btsc, in complexes 1 and 3) or 5,6-diphenyltriazine-3-one (Bsc, in complexes 2 and 4). The data were consistent with cis arrangement of the biphosphine ligands. For the Btsc and Bsc ligands, the data pointed to monoanionic bidentate coordination to ruthenium(II) through N,S and N,O, respectively. Single-crystal X-ray diffraction showed that complex 1 crystallized in the monoclinic system, space group P21/c. Determination of the cytotoxicity profiles of complexes 1-4 gave SI values ranging from 1.19 to 3.50 against the human lung adenocarcinoma cell line A549 and the non-tumor lung cell line MRC-5. Although the molecular docking studies suggested that the interaction between DNA and complex 4 was energetically favorable, the experimental results showed that they interacted weakly. Overall, our results demonstrated that these novel ruthenium(II) complexes have interesting in vitro antitumor potential and this study may contribute to further studies in medicinal inorganic chemistry.


Assuntos
Antineoplásicos , Complexos de Coordenação , Neoplasias Pulmonares , Rutênio , Semicarbazonas , Humanos , Complexos de Coordenação/química , Rutênio/farmacologia , Rutênio/química , Linhagem Celular Tumoral , Ligantes , Simulação de Acoplamento Molecular , Semicarbazonas/farmacologia , Antineoplásicos/química , Apoptose , Neoplasias Pulmonares/tratamento farmacológico , Movimento Celular , Pulmão
2.
Biometals ; 31(6): 1003-1017, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30284643

RESUMO

Leishmaniasis, a neglected tropical disease caused by protozoans of the genus Leishmania, kills around 20-30 thousand people in Africa, Asia, and Latin America annually and, despite its potential lethality, it can be treated and eventually cured. However, the current treatments are limited owing to severe side effects and resistance development by some Leishmania. These factors make it urgent to develop new leishmanicidal drugs. In the present study, three ruthenium(II) organometallic complexes containing as ligands the commercially available anti-inflammatories diclofenac (dic), ibuprofen (ibu), and naproxen (nap) were synthesized, characterized, and subjected to in vitro leishmanicidal activity. The in vitro cytotoxicity assays against Leishmania (L.) amazonensis and Leishmania (L.) infantum promastigotes have shown that complexes [RuCl(dic)(η6-p-cymene)] (1) and [RuCl(nap)(η6-p-cymene)] (3) were active against both Leishmania species. Complex [RuCl(ibu)(η6-p-cymene)] (2) has exhibited no activity. The IC50 values for the two active complexes were respectively 7.42 and 23.55 µM, for L. (L.) amazonensis, and 8.57 and 42.25 µM, for L. (L.) infantum. Based on the toxicological results and computational analysis, we proposed a correlation between the complexes and their activity. Our results suggest both complexation to ruthenium(II) and ligands structure are key elements to leishmanicidal activity.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Leishmania/efeitos dos fármacos , Leishmaniose/tratamento farmacológico , Compostos Organometálicos/farmacologia , Rutênio/farmacologia , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Relação Dose-Resposta a Droga , Leishmania/citologia , Ligantes , Modelos Moleculares , Compostos Organometálicos/síntese química , Compostos Organometálicos/química , Testes de Sensibilidade Parasitária , Rutênio/química , Relação Estrutura-Atividade
3.
J Inorg Biochem ; 175: 225-231, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28783554

RESUMO

Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania. The many complications presented by the current treatment - including high toxicity, high cost and parasite resistance - make the development of new therapeutic agents indispensable. The present study aims to evaluate the anti-Leishmania potential of new ruthenium(II) complexes, cis­[RuII(η2-O2CR)(dppm)2]PF6, with dppm=bis(diphenylphosphino)methane and R=4-butylbenzoate (bbato) 1, 4-(methylthio)benzoate (mtbato) 2 and 3-hydroxy-4-methoxybenzoate (hmxbato) 3, in promastigote cytotoxicity and their effect on parasite-host interaction. The cytotoxicity of complexes was analyzed by MTT assay against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, Leishmania (Leishmania) infantum promastigotes and the murine macrophage (RAW 264.7). The effect of complexes on parasite-host interaction was evaluated by in vitro infectivity assay performed in the presence of two different concentrations of each complex: the promastigote IC50 value and the concentration nontoxic to 90% of RAW 264.7 macrophages. Complexes 1-3 exhibited potent cytotoxic activity against all Leishmania species assayed. The IC50 values ranged from 7.52-12.59µM (complex 1); 0.70-3.28µM (complex 2) and 0.52-1.75µM (complex 3). All complexes significantly inhibited the infectivity index at both tested concentrations. The infectivity inhibitions ranged from 37 to 85%. Interestingly, the infectivity inhibitions due to complex action did not differ significantly at either of the tested concentrations, except for the complex 1 against Leishmania (Leishmania) infantum. The infectivity inhibitions resulted from reductions in both percentage of infected macrophages and number of parasites per macrophage. Taken together the results suggest remarkable leishmanicidal activity in vitro by these new ruthenium(II) complexes.


Assuntos
Antiprotozoários , Complexos de Coordenação , Interações Hospedeiro-Parasita/efeitos dos fármacos , Leishmania/fisiologia , Leishmaniose/tratamento farmacológico , Rutênio , Animais , Antiprotozoários/síntese química , Antiprotozoários/química , Antiprotozoários/farmacologia , Complexos de Coordenação/síntese química , Complexos de Coordenação/química , Complexos de Coordenação/farmacologia , Macrófagos/parasitologia , Camundongos , Células RAW 264.7 , Rutênio/química , Rutênio/farmacologia
4.
Food Chem ; 209: 293-301, 2016 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-27173566

RESUMO

Overall phenolic content in plants is on average higher in organic farming, including when renewable resources such as composts are used as soil amendments. In most cases, however, the composting process needs to be optimized to reach the desired outcome. Using composts obtained from chestnut, red and white grapes, olive and broccoli wastes, the relative antioxidative abilities of lettuces cultivated in greenhouse were examined. Results clearly coupled high phenolic levels with high yield in lettuce grown on the chestnut-based compost. A huge accumulation of phenolics was observed with the white grape-based compost, but this coincided with low yield. Three compounds were identified as discriminating factors between treated samples, namely quercetin 3-O-glucoside, luteolin 7-O-glucoside, and cyanidin 3-O-(6″-malonyl)-ß-d-glucoside; these are also some of the compounds receiving health claims on lettuce consumption. On a negative note, all composts led to decreased vitamin C levels. Collectively, the data suggest that compost amendments can help add value to lettuce by increasing its antioxidant activity as compared to other organic resources.


Assuntos
Ácido Ascórbico/análise , Fertilizantes , Resíduos Industriais , Lactuca/crescimento & desenvolvimento , Agricultura Orgânica/métodos , Fenóis/análise , Solo/química , Antocianinas/análise , Antioxidantes/análise , Flavonas/análise , Flavonoides/análise , Glucosídeos/análise , Lactuca/química , Olea/química , Quercetina/análogos & derivados , Vitis/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA